Direxion Daily Semicondct Bull 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Direxion Daily Small Cap Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily Technology Bull 3X ETF

Direxion Daily Gold Miners Bear 3X ETF

Guggenheim Solar ETF

Bank Of Montreal

VS TR -1x Short VIX Futures ETF

Direxion Daily Semicondct Bear 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Direxion Daily Small Cap Bear 3X ETF

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P Biotech Bear 3X ETF

VS TR 2x Long VIX Futures ETF

Direxion Technology Bear 3X Shares

Direxion Daily Gold Miners Bull 3X ETF

ProShares Ultra VIX Short-Term Futures

ChargePoint Holdings Inc. Common Stock

Helmerich & Payne Inc. Common Stock

Northern Oil and Gas Inc. Common Stock

Brunswick Corporation Common Stock

Vistra Corp. Common Stock

Winnebago Industries Inc. Common Stock

Olin Corporation Common Stock

Cactus Inc. Class A Common Stock

Hexcel Corporation Common Stock

Hillenbrand Inc Common Stock

Stride Inc. Common Stock

Oklo Inc.

Kroger Company (The) Common Stock

Agnico Eagle Mines Limited Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Hims & Hers Health Inc. Class A Common Stock

Gold Fields Limited American Depositary Shares

Twilio Inc. Class A Common Stock

Alamos Gold Inc. Class A Common Shares

Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)

Click here to get full coverage on ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote - Stock Titan

ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote  Stock Titan

ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote - Stock Titan

Click here to get full coverage on SLRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ACELYRIN, Inc. Is Fair to Shareholders - Business Wire

SLRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ACELYRIN, Inc. Is Fair to Shareholders  Business Wire

SLRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ACELYRIN, Inc. Is Fair to Shareholders - Business Wire

Click here to get full coverage on Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now? - Yahoo Finance

Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now?  Yahoo Finance

Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates  GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

Click here to get full coverage on Acelyrin stock gains as Trium rebuffs M&A deal (SLRN:NASDAQ) - Seeking Alpha

Acelyrin stock gains as Trium rebuffs M&A deal (SLRN:NASDAQ)  Seeking Alpha

Acelyrin stock gains as Trium rebuffs M&A deal (SLRN:NASDAQ) - Seeking Alpha

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, SLRN, BECN on Behalf of Shareholders - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, SLRN, BECN on Behalf of Shareholders  PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, SLRN, BECN on Behalf of Shareholders - PR Newswire

Click here to get full coverage on Acelyrin, Inc.(NasdaqGS: SLRN) dropped from S&P TMI Index - marketscreener.com

Acelyrin, Inc.(NasdaqGS: SLRN) dropped from S&P TMI Index  marketscreener.com

Acelyrin, Inc.(NasdaqGS: SLRN) dropped from S&P TMI Index - marketscreener.com

Click here to get full coverage on Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now - Insider Monkey

Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now  Insider Monkey

Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now - Insider Monkey

Click here to get full coverage on $737 Million Deal Reshapes Immunology Sector: Inside Alumis and ACELYRIN's Strategic Merger Revolution - Stock Titan

$737 Million Deal Reshapes Immunology Sector: Inside Alumis and ACELYRIN's Strategic Merger Revolution  Stock Titan

$737 Million Deal Reshapes Immunology Sector: Inside Alumis and ACELYRIN's Strategic Merger Revolution - Stock Titan

Click here to get full coverage on ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN - Business Wire

ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN  Business Wire

ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN - Business Wire

Click here to get full coverage on Acelyrin stock in focus after poison pill (SLRN:NASDAQ) - Seeking Alpha

Acelyrin stock in focus after poison pill (SLRN:NASDAQ)  Seeking Alpha

Acelyrin stock in focus after poison pill (SLRN:NASDAQ) - Seeking Alpha

Click here to get full coverage on ACELYRIN-Alumis Merger Gets Green Light: New Powerhouse in Immune Disease Treatment Emerges - Stock Titan

ACELYRIN-Alumis Merger Gets Green Light: New Powerhouse in Immune Disease Treatment Emerges  Stock Titan

ACELYRIN-Alumis Merger Gets Green Light: New Powerhouse in Immune Disease Treatment Emerges - Stock Titan

Click here to get full coverage on Alumis stock falls on merger deal with Acelyrin (SLRN:NASDAQ) - Seeking Alpha

Alumis stock falls on merger deal with Acelyrin (SLRN:NASDAQ)  Seeking Alpha

Alumis stock falls on merger deal with Acelyrin (SLRN:NASDAQ) - Seeking Alpha

Click here to get full coverage on ACELYRIN's Defensive Move: New Rights Plan Blocks Hostile Takeover After Major Stake Purchase - Stock Titan

ACELYRIN's Defensive Move: New Rights Plan Blocks Hostile Takeover After Major Stake Purchase  Stock Titan

ACELYRIN's Defensive Move: New Rights Plan Blocks Hostile Takeover After Major Stake Purchase - Stock Titan

Click here to get full coverage on Acelyrin stock falls after TED drug data (SLRN:NASDAQ) - Seeking Alpha

Acelyrin stock falls after TED drug data (SLRN:NASDAQ)  Seeking Alpha

Acelyrin stock falls after TED drug data (SLRN:NASDAQ) - Seeking Alpha

Click here to get full coverage on Shareholder Alert: Ademi & Fruchter LLP investigates whether ACELYRIN, INC. is obtaining a Fair Price for its Public Shareholders - Business Wire

Shareholder Alert: Ademi & Fruchter LLP investigates whether ACELYRIN, INC. is obtaining a Fair Price for its Public Shareholders  Business Wire

Shareholder Alert: Ademi & Fruchter LLP investigates whether ACELYRIN, INC. is obtaining a Fair Price for its Public Shareholders - Business Wire

Click here to get full coverage on Hungry Hungry Nova - Astrobites

Hungry Hungry Nova - Astrobites

Click here to get full coverage on Best-fit DUSTY model of the ZTF SLRN-2020 SED from archival P48+ZTF,... | Download Scientific Diagram - researchgate.net

Best-fit DUSTY model of the ZTF SLRN-2020 SED from archival P48+ZTF,... | Download Scientific Diagram  researchgate.net

Best-fit DUSTY model of the ZTF SLRN-2020 SED from archival P48+ZTF,... | Download Scientific Diagram - researchgate.net

Click here to get full coverage on ZTF SLRN-2020, the star that swallowed a planet - BBC Sky at Night Magazine

ZTF SLRN-2020, the star that swallowed a planet  BBC Sky at Night Magazine

ZTF SLRN-2020, the star that swallowed a planet - BBC Sky at Night Magazine

Click here to get full coverage on Fenwick Represents ACELYRIN in Pending Merger with Alumis - fenwick.com

Fenwick Represents ACELYRIN in Pending Merger with Alumis  fenwick.com

Fenwick Represents ACELYRIN in Pending Merger with Alumis - fenwick.com

Click here to get full coverage on ACELYRIN Completes Merger and Delists from Nasdaq - TipRanks

ACELYRIN Completes Merger and Delists from Nasdaq  TipRanks

ACELYRIN Completes Merger and Delists from Nasdaq - TipRanks

Click here to get full coverage on First-ever recorded planetary engulfment event captured by Webb - Earth.com

First-ever recorded planetary engulfment event captured by Webb  Earth.com

First-ever recorded planetary engulfment event captured by Webb - Earth.com

Click here to get full coverage on ACELYRIN Stockholders Approve Merger with Alumis - TipRanks

ACELYRIN Stockholders Approve Merger with Alumis  TipRanks

ACELYRIN Stockholders Approve Merger with Alumis - TipRanks

Click here to get full coverage on Acelyrin should liquidate instead of merging with Alumis, investor says - BioPharma Dive

Acelyrin should liquidate instead of merging with Alumis, investor says  BioPharma Dive

Acelyrin should liquidate instead of merging with Alumis, investor says - BioPharma Dive

Click here to get full coverage on Acelyrin rebuffs Concentra bid, believing Alumis option better - The Pharma Letter

Acelyrin rebuffs Concentra bid, believing Alumis option better  The Pharma Letter

Acelyrin rebuffs Concentra bid, believing Alumis option better - The Pharma Letter

Click here to get full coverage on STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF - PR Newswire

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF  PR Newswire

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF - PR Newswire

Click here to get full coverage on Figure 3. Best-fit Gaussian profile model of the Brα emission line... - researchgate.net

Figure 3. Best-fit Gaussian profile model of the Brα emission line...  researchgate.net

Figure 3. Best-fit Gaussian profile model of the Brα emission line... - researchgate.net

Click here to get full coverage on Last-minute suitor nearly upends Alumis, Acelyrin merger - The Business Journals

Last-minute suitor nearly upends Alumis, Acelyrin merger  The Business Journals

Last-minute suitor nearly upends Alumis, Acelyrin merger - The Business Journals

Click here to get full coverage on Acelyrin deprioritises lead therapy despite Phase III win, fires 33% of staff - Clinical Trials Arena

Acelyrin deprioritises lead therapy despite Phase III win, fires 33% of staff  Clinical Trials Arena

Acelyrin deprioritises lead therapy despite Phase III win, fires 33% of staff - Clinical Trials Arena

Click here to get full coverage on Acelyrin shifts from main drug, lays off staff - BioPharma Dive

Acelyrin shifts from main drug, lays off staff  BioPharma Dive

Acelyrin shifts from main drug, lays off staff - BioPharma Dive

Click here to get full coverage on ACELYRIN, INC. Ends Key Agreement with Affibody - TipRanks

ACELYRIN, INC. Ends Key Agreement with Affibody  TipRanks

ACELYRIN, INC. Ends Key Agreement with Affibody - TipRanks

Click here to get full coverage on Webb Telescope's Planetary 'Autopsy' Reveals Surprising Cause of Death - extremetech.com

Webb Telescope's Planetary 'Autopsy' Reveals Surprising Cause of Death  extremetech.com

Webb Telescope's Planetary 'Autopsy' Reveals Surprising Cause of Death - extremetech.com

Click here to get full coverage on Zee News Rajasthan Stories - WION

Zee News Rajasthan Stories - WION

Click here to get full coverage on Alumis, ACELYRIN amend proposed merger pact - Seeking Alpha

Alumis, ACELYRIN amend proposed merger pact  Seeking Alpha

Alumis, ACELYRIN amend proposed merger pact - Seeking Alpha

Click here to get full coverage on ACELYRIN shareholders approve Alumis merger deal - Investing.com

ACELYRIN shareholders approve Alumis merger deal  Investing.com

ACELYRIN shareholders approve Alumis merger deal - Investing.com

Click here to get full coverage on ACELYRIN, INC. Amends Merger Agreement with Alumis - TipRanks

ACELYRIN, INC. Amends Merger Agreement with Alumis  TipRanks

ACELYRIN, INC. Amends Merger Agreement with Alumis - TipRanks

Click here to get full coverage on Alumis and ACELYRIN announce definitive merger plan - Investing.com

Alumis and ACELYRIN announce definitive merger plan  Investing.com

Alumis and ACELYRIN announce definitive merger plan - Investing.com

Click here to get full coverage on Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger - Endpoints News

Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger  Endpoints News

Acelyrin rejects buyout offer from Tang’s Concentra, sticks to Alumis merger - Endpoints News

Click here to get full coverage on Star Eats Planet, Brightens Dramatically - Caltech

Star Eats Planet, Brightens Dramatically  Caltech

Star Eats Planet, Brightens Dramatically - Caltech

Click here to get full coverage on Revised merger terms boost ACELYRIN stake in Alumis deal - Investing.com

Revised merger terms boost ACELYRIN stake in Alumis deal  Investing.com

Revised merger terms boost ACELYRIN stake in Alumis deal - Investing.com

Click here to get full coverage on TANG CAPITAL MANAGEMENT LLC Increases Stake in Acelyrin Inc - GuruFocus

TANG CAPITAL MANAGEMENT LLC Increases Stake in Acelyrin Inc  GuruFocus

TANG CAPITAL MANAGEMENT LLC Increases Stake in Acelyrin Inc - GuruFocus

Click here to get full coverage on Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure - Endpoints News

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure  Endpoints News

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure - Endpoints News

Click here to get full coverage on ACELYRIN, INC. (SLRN) - Zacks Investment Research

ACELYRIN, INC. (SLRN)  Zacks Investment Research

ACELYRIN, INC. (SLRN) - Zacks Investment Research

Click here to get full coverage on Acelyrin (SLRN) Stock Price, News & Analysis - MarketBeat

Acelyrin (SLRN) Stock Price, News & Analysis  MarketBeat

Acelyrin (SLRN) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on SLRN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

SLRN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit  Business Wire

SLRN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Click here to get full coverage on Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021 - BioPharma Dive

Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021  BioPharma Dive

Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021 - BioPharma Dive

Click here to get full coverage on ACELYRIN, INC. Announces Pricing of Upsized Initial Public Offering - PR Newswire

ACELYRIN, INC. Announces Pricing of Upsized Initial Public Offering  PR Newswire

ACELYRIN, INC. Announces Pricing of Upsized Initial Public Offering - PR Newswire

Click here to get full coverage on Acelyrin readies biggest biotech IPO so far this year with $540M upsized offering - Fierce Biotech

Acelyrin readies biggest biotech IPO so far this year with $540M upsized offering  Fierce Biotech

Acelyrin readies biggest biotech IPO so far this year with $540M upsized offering - Fierce Biotech

Click here to get full coverage on Why Acelyrin Stock Plummeted 59% This Week - The Motley Fool

Why Acelyrin Stock Plummeted 59% This Week  The Motley Fool

Why Acelyrin Stock Plummeted 59% This Week - The Motley Fool

Click here to get full coverage on SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range? - InvestorPlace

SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?  InvestorPlace

SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range? - InvestorPlace

Click here to get full coverage on Astronomers just saw a star eat a planet – an astrophysicist on the team explains the first-of its-kind discovery - The Conversation

Astronomers just saw a star eat a planet – an astrophysicist on the team explains the first-of its-kind discovery  The Conversation

Astronomers just saw a star eat a planet – an astrophysicist on the team explains the first-of its-kind discovery - The Conversation

Click here to get full coverage on Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline  marketscreener.com

Levi & Korsinsky Notifies Acelyrin, Inc.(SLRN) Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Click here to get full coverage on ACELYRIN - Crunchbase

ACELYRIN - Crunchbase

Click here to get full coverage on Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Ameriprise Financial Inc. - Defense World

Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Ameriprise Financial Inc.  Defense World

Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Ameriprise Financial Inc. - Defense World

Click here to get full coverage on Acelyrin, Inc. (NASDAQ:SLRN) Shares Bought by Deutsche Bank AG - Defense World

Acelyrin, Inc. (NASDAQ:SLRN) Shares Bought by Deutsche Bank AG  Defense World

ACELYRIN, INC. Common Stock (SLRN)

Price Chart

Key Statistics

Technicals

About SLRN

Latest News

ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote - Stock Titan

SLRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ACELYRIN, Inc. Is Fair to Shareholders - Business Wire

Is Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now? - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers